CPT code 87267 represents a direct fluorescent antibody (DFA) laboratory test used to detect enterovirus antigens in patient specimens. As a targeted virology diagnostic, this code supports clinical decision-making for suspected enteroviral infections and can influence infection control, antiviral management, and patient disposition. Nationally, accurate laboratory coding for antigen detection affects claims processing, lab utilization reporting, and public health surveillance.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find concise benchmarks for utilization and billing context, clinical background on the DFA method for enterovirus detection, common coding and billing considerations, and an overview of how this service is typically delivered across laboratory and hospital settings. The publication highlights operational factors relevant to labs and billing teams, and summarizes typical sites of service and service type.

Data not available in the input for specific payor rates, taxonomies, ICD-10 crosswalks, and related codes is noted where applicable.